Genmab secures global rights to Scancell antibody
![Photo: Tuala Hjarnø / Genmab / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14528118.ece/ALTERNATES/schema-16_9/doc7ncfm47d5yf1mv3yrk21.jpg)
Biotech firm Genmab has expanded its pipeline by acquiring the global rights to a monoclonal antibody developed by UK-based Scancell.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.